Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-01-16

FDA Approved: SUCRALFATE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for SUCRALFATE submitted by Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUCRALFATE (SUCRALFATE)

Snippet

SUPPL AP for SUCRALFATE (SUCRALFATE)